BioCentury
ARTICLE | Clinical News

NormoCort: Phase III started

September 1, 2014 7:00 AM UTC

Cortendo began the open-label, international Phase III SONICS trial to evaluate ascending doses of twice-daily oral NormoCort in about 90 patients with Cushing’s syndrome. The trial comprises a dose-t...